DNAlite Therapeutics, Inc. is a biotechnology company developing a proprietary vector for gene therapy applications in the gastrointestinal tract.
Location: United States, California, San Francisco
Employees: 11-50
Total raised: $1.5M
Founded date: 2016
Investors 4
| Date | Name | Website |
| 05.04.2023 | SeedFolio | seedfolio.... |
| - | Berkeley C... | berkeleyca... |
| - | SVE Capita... | sve-capita... |
| - | Blue Bear ... | bbv.io/ |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 08.08.2018 | - | $1.5M | - |
Mentions in press and media 3
| Date | Title | Description |
| 09.08.2018 | Term Sheet — Thursday, August 9 | NO DEAL Good morning, Term Sheet readers. Paid Content You can't secure what you can't see From ExtraHop Rite Aid CEO John Standley said that the pharmacy chain had been unable to convince shareholders of the merits to the merger. Grocery g... |
| 08.08.2018 | Gastrointestinal Gene Therapy Biotech Company DNAlite Therapeutics Raises $1.5M | DNAlite Therapeutics, a San Francisco, CA-based gastrointestinal gene therapy biotech company, raised $1.5M in seed funding. The round was led by Berkeley-based Berkeley Catalyst Fund with participation from University of California Berkele... |
| 14.09.2017 | Tune in to IndieBio Accelerator’s Demo Day today | TechCrunch is excited to bring you IndieBio Accelerator‘s Demo Day today, September 14th at 3:00pm PT. Targeting the biotech industry, the IndieBio Accelerator hosts a four-month program. IndieBio provides startups with 24/7 access to biosa... |